Vizient Newsroom

Vizient, Inc. released its Summer 2022 Pharmacy Market Outlook forecasting a 3.26% overall drug price inflation rate for the calendar year beginning Jan. 1, 2023. The rate reflects a continued trend toward moderation of the overall increase in drug prices, a result of the balance between the increased use of high-cost medications, the introduction of lower-cost generic drugs and greater utilization of biosimilars.

Vizient, Inc., the nations' largest member-driven health care performance improvement company, today announced a strategic partnership agreement with Mpirik, a cloud-based care pathway software company focused on cardiac care, that will enable physicians to make more informed decisions on patient care while helping to reduce undertreatment.

In order to face the variety of challenges in meeting the demand for hospital laboratory services, a better test selection process is needed. Adapting the 5Rs to your demand management program can support enhanced patient care while improving laboratory capabilities, responsiveness and reduced costs. 

A successful health equity strategy starts with better measurement and effective communication.